Health Economics & Evidence Synthesis NCL
@HEconEvSynNCL
Followers
3K
Following
1K
Media
178
Statuses
2K
Updates from the Health Economics & Evidence Synthesis Team. Part of @UniofNewcastle Population Health Sciences Institute. Account mainly run by @TomosRobinson1
Newcastle upon Tyne
Joined April 2014
Come join our team! . We are recruiting a Senior Research Associate in Health Technology Assessment (HTA) and modelling: Closing Date: 28 May 2025 . #healtheconomics #HTA.
0
2
2
RT @NIHRHAPRU: 📢Check out our new blog from @KunongaPatience: "Improving methods for studying Health Inequality and Inequity in evidence sy….
0
2
0
RT @pubhealthjobsuk: Research Assistant in Health Economics.Newcastle University.Newcastle upon Tyne.£32,546 - £34,132.Closes 28/03. https:….
0
5
0
Come work with us! We are recruiting a Research Assistant in Health Economics. Deadline for applications 28/03/25. All details can be found here: #healtheconomics RT.
0
4
1
RT @Healtheconall: New Research Assistant (Health Economics) Post Newcastle University, UK #healtheconomics.
0
1
0
New paper in @JPRO_ISOQOL: "A #systematicreview of condition-specific preference-based measures used in young people and their valuation methods" by @__willking, Lauren Hockley, @DrAngelaBate, @TomosRobinson1 & @Lauraternent1: #healtheconomics RT
0
1
5
RT @greig_d_taylor: 📝Public Valuations of managing compromised molars: a discrete choice experiment. Restoring a cFPM in a child was valued….
0
2
0
Do you live in the UK, have experienced pelvic organ prolapse and want to shape research on how to manage prolapse without surgery? Learn more about a new project and express your interest to join the Patient Advisory Group: #WomensHealth #PPIE RT
0
0
0
RT @Healtheconall: Research Assistant/Research Associate (Health Economics) Newcastle University, UK #healtheconomi….
0
2
0
New publication in Vaccine X by HEG PhD student @RohanPandey7: " The cost-effectiveness of #COVID19 vaccination program among age-groups children, adults, and elderly in Europe: A #systematicreview". Paper link: #healtheconomics RT
0
0
2
New guidance published by @NICEComms yesterday for Elafibranor. The EAG report for this was prepared by the Newcastle TAR Group #healtheconomics RT.
Around 3,600 people in England with a type of chronic liver disease are set to benefit after a new treatment has been recommended by NICE. Find out more about elafibranor, a new daily pill for treating primary biliary cholangitis:
0
0
1
New article in @ClinOncology feat @GurdeepNCL: "OSAIRIS: Lessons Learned From the Hospital-Based Implementation and Evaluation of an Open-Source Deep-Learning Model for Radiotherapy Image Segmentation": #oncology RT
0
1
3
New #HTA report: Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: #systematicreview and cost-effectiveness analysis by Shabaninejad et al @RyanPWKenny @TomosRobinson1 @Akvile_01 @FionaBeyer: @NIHRresearch
0
0
3
RT @John_Wildman_: As the Peter and Norah Lomas chair in economics it gives me great pleasure to announce the latest opening for the Lomas….
0
2
0
📢New study on the effectiveness of Advanced Care Plans for older adults without life-limiting conditions! Discover insights into their impact on hospital readmissions, cultural acceptability, and feasibility #Healthcare #Aging @KunongaPatience @dawn_craig.
1
2
5
RT @NIHRTechEvalHRC: 📣 The Methods for Economic Evaluation of Diagnostics, Digital, Data and Devices Research Forum is back on 28 November….
0
3
0
RT @helendentist: Delighted to introduce a new short course on Health Economics in Oral Health at @NewcastleSDS with myself, @KCarr20 @chri….
0
9
0
More medication options for #BipolarDepression will allow better long-term treatment for this condition. Our #systematicreview showed Cariprazine has efficacy in treating major depressive episodes although this varies between those with BD and MDD: RT
0
1
2